Inventurus Knowledge Solutions IPO subscribed overall 52.68 times on the last day, while A retail quota was subscribed 14.55 times, QIB was subscribed 80.64 times, and NII quota subscribed 23.25 times respectively.
Details About Inventurus Knowledge Solutions IPO
Inventurus Knowledge Solutions got approval from SEBI for an IPO of ₹2,497.92 crores which is offer for sale up to 1,87,95,510 equity shares with a face value of ₹1 each. This IPO aims to raise funds and maintain financial stability. Moreover, the company has set up a price band between ₹1265 to ₹1329 per share. In this IPO, a total of 11 shares were available in 1 lot size for the minimum Retail category, and for the maximum retail category, 143 shares were available in 13 lot sizes, For S-HNI (Min), a total of 154 shares were available in 14 lot sizes. While, as for B-HNI, a Minimum total of 759 shares was available in 69 lot sizes.
To invest in this IPO, each investor category has specific investment amounts:
- Retail Investors: Minimum investment of ₹14,619 and maximum investment of ₹190,047
- Small HNI (S-HNI): Minimum investment of ₹204,666
- Big HNI (B-HNI): Minimum investment of ₹1,008,711.
Subscription duration of IKS IPO
The Inventurus Knowledge IPO subscription opening date was 12 December and the close date was 16 December. The Inventurus Knowledge IPO allotment was finalized on December 17 and the IPO listing is on December 19.
Funds Deployment of This Company
The company plans to use the money raised from the new shares for the following purposes:
The company will not receive any proceeds from the Offer and all such proceeds (net of any Offer related expenses to be borne by the Selling Shareholders) will go to the Selling Shareholders.
About Inventurus Knowledge Solutions IPO
Inventurus Knowledge Solutions is a substantial platform for health organizations to provide advanced and innovative technology services to improve patients’ health. The main markets for these services are the US, Canada, and Australia. This platform assists doctors and healthcare providers in better care, managing patients’ health more effectively, and moving from the old “fee-for-service” payment model to a “fee-for-value” model. Over a period, 800 healthcare organizations have been established as clients and health systems such as ancillary healthcare organizations, multi-specialty medical groups, and single-specialty medical groups. Mass General Brigham Inc., Texas Health Care PLLC and The GI Alliance Management are key clients of this healthcare solution. Moreover, the revenue of FY 2024 is INR 1,817.93 crores and the net income was INR 370.49 crores which was increased compared to the last two years. Providing offer solutions and the main priorities of customers leading many awards are below the lines.
Healthcare Leadership Award in 2019, Best Blended Learning Award in 2020, TISS LeapVault CLO Award in 2021, and Top 3 in Innovation in Analytics in 2022.
IKS IPO Financial Background
The company reported revenue of ₹1,817.93 crores in 2024 against ₹1,031.30 crores in 2023. The company reported Profit of ₹370.49 crores in 2024 against Profit of ₹305.23 crores in 2023.
